Biovie Inc.
BIVIW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580149
In the last 90 days, Biovie Inc. insiders filed 4 open-market purchases and 0 sales; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.07M in total; no superinvestor holds it.
Other share classesBIVI
13F holders, Q4 2025
Institutional positions in Biovie Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- +1 vs. Q3 2025
- Shares held
- 2.20M
- +572.4K (+35.2%) vs. Q3 2025
- Total value
- $595.8K
- −$137.9K (−18.8%) vs. Q3 2025
- New holders
- 1
- 3 more added
- Sold out
- 0
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIVIW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $1.07M |
| Q1 2026 | 8 | $691.1K |
| Q4 2025 | 9 | $595.8K |
| Q3 2025 | 8 | $733.7K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Biovie Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Diametric Capital, LP | 750,000 | $203.3K | 0.05% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 461,937 | $138.8K | 0.04% | +180,454+64.1% | Added |
| Armistice Capital, LLC | 500,000 | $128.6K | 0.00% | +500,000 | New |
| Prelude Capital Management, LLC | 186,621 | $48.0K | 0.00% | −106,815−36.4% | Reduced |
| MYDA Advisors LLC | 174,000 | $44.7K | 0.01% | −1,000−0.6% | Reduced |
| Heights Capital Management, Inc | 90,000 | $23.1K | 0.01% | 00.0% | Unchanged |
| Cerity Partners LLC | 20,112 | $5.45K | 0.00% | +11+0.1% | Added |
| Two Sigma Securities, LLC | 14,038 | $3.80K | 0.00% | +328+2.4% | Added |
| UBS Group AG | 425 | $115 | 0.00% | −575−57.5% | Reduced |